Healio

Oral medication lowers IGF-1 levels below upper limit of normal for most with acromegaly

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The PATHFNDR-2 trial enrolled adults with acromegaly who ...
Monthly Prescribing Reference

Paltusotine Looks Promising for Acromegaly in Phase 3 Trial

Findings showed 56% of patients who received paltusotine achieved an IGF-1 level equal to or less than 1 times the ULN compared with 5% of those who received placebo. Treatment with paltusotine ...
Nature

Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review

We present a review of the epidemiological evidence for relations of prostate cancer risk to circulating total and bioavailable androgens, to alterations in the metabolism of insulin-like growth ...
Healio

Oral acromegaly agent reduces IGF-1 levels below upper limit of normal for most adults

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio More than 80% of adults with acromegaly ...